BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 28456796)

  • 1. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
    Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H
    Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
    Li Y; Ye Y; Feng B; Qi Y
    J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
    Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
    Wang J; Yang K; Yang X; Jin T; Tian Y; Dai C; Xu F
    Mol Carcinog; 2024 Jul; 63(7):1275-1287. PubMed ID: 38578157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
    Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Tu K; Liu Z; Yao B; Han S; Yang W
    Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway.
    Hua H; Zhu Y; Song YH
    Biomed Pharmacother; 2018 May; 101():115-122. PubMed ID: 29477471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
    Wang X; Zeng J; Wang L; Zhang X; Liu Z; Zhang H; Dong J
    Oncol Rep; 2017 Jul; 38(1):141-150. PubMed ID: 28586051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
    Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
    Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.